Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
US-12509687-B2 · Dec 30, 2025 · US
This page is not indexed by search engines while we improve data quality.
Gong Da-Wei patents
Gong Da-Wei is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Gong Da-Wei |
| Total patents | 12 |
| First publication | Aug 10, 2017 |
| Latest publication | Dec 30, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors
US-2024076674-A1 · Mar 7, 2024 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors
US-2023263821-A1 · Aug 24, 2023 · US
Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
US-11713461-B2 · Aug 1, 2023 · US
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
US-11504390-B2 · Nov 22, 2022 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors
US-2022323483-A1 · Oct 13, 2022 · US
Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (SCAP) inhibitors
US-11331332-B2 · May 17, 2022 · US
Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors
US-2021002647-A1 · Jan 7, 2021 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) Inhibitors
US-2020297753-A1 · Sep 24, 2020 · US
Treatment Of Increased Lipid Levels With Sterol Regulatory Element Binding Transcription Factor 1 (SREBF1) Inhibitors
US-2020297752-A1 · Sep 24, 2020 · US
Recent patents
Latest publications not already listed above.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Maryland | 12 |
| Regeneron Pharma | 10 |
| Regeneran Pharmaceuticals Inc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12Q1/6883 | 10 |
| C12N2310/20 | 10 |
| C12Q2600/156 | 10 |
| C12N15/113 | 7 |
| C12Q1/6827 | 6 |